Tissue Diagnostics Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Mexico, Brazil, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Tissue Diagnostics Market size is expected to grow significantly from 2019 to 2025.
 

Tissue diagnostics market growth is attributable to the growing prevalence of cancer globally. According to World Health Organization, cancer is the second leading cause of mortality worldwide, accounting for over 9.5 million deaths in 2018. Changing lifestyle, increasing consumption of tobacco & alcohol and rising prevalence of lifestyle disorders has escalated the number of people suffering from cancer. Additionally, government initiatives to increase awareness regarding effective and early cancer diagnosis will fuel the demand for tissue diagnostic tests, thereby augmenting industry growth. Rising public and private funding will further foster the tissue diagnostics business growth over the forecast period.
 

Furthermore, growing demand for personalized medicine, surge in adoption of companion & molecular diagnostics as well as increasing opportunities in digital pathology will serve to be major factors driving industry growth. Innovations in tissue diagnostics market including inception of automated tissue diagnostics to enhance assay performance and effectively minimize the number of pathologists needed for assistance will favor business growth. However, stringent regulatory policies and lack of awareness regarding tissue diagnostics in underdeveloped regions may impede industry growth during the forthcoming years.
 

Breast cancer segment held substantial revenue share in 2018 and is projected to witness lucrative growth over the forecast period. Growing prevalence of breast cancer in developed as well as developing countries is the key factor driving segment growth. Advent in technology coupled with increasing focus on research activities for developing advanced technologies will spur the business revenue. Awareness regarding effective breast cancer diagnosis will surge the demand for tissue diagnostics over the coming years.
 

Immunohistochemistry (IHC) segment accounted for significant revenue share in 2018 and is anticipated to grow during the analysis period. Segment growth is attributed to growing demand for in-vitro diagnostics and availability of large number of products based on the IHC technology.
 

Hospitals segment is estimated to exhibit high growth over the forecast timeframe due to increasing number of hospital admissions. Cancer patients requiring continuous monitoring prefer minimally invasive procedures carried out in hospitals settings. Availability of technologically advanced biopsy, mammography and other devices utilized in cancer diagnosis and treatment in hospitals will further favor segment growth.
 

North America tissue diagnostics market held momentous revenue in 2018 and will show similar trend over the analysis period. Rapidly growing geriatric population base coupled with rising incidence of cancer in North America will drive regional tissue diagnostics market growth. Availability of technologically advanced cancer diagnostic techniques, government support towards development of advanced diagnostic platforms and favorable R&D initiatives by industry players will upsurge North America tissue diagnostics industry growth.
 

Some of the prominent players operating in tissue diagnostics market include Agilent, Abbott Laboratories, Merck, Roche, Danaher, Sigma Aldrich, BioGenex Laboratories, Cancer Genetics, Definiens, Genomic Health and Thermo Fisher Scientific. Companies mainly focus on innovative product launch as well as strategic alliances including partnerships and acquisitions to capitalize on market opportunities and gain more market share.

Tissue Diagnostics Market By Product, 2014-2025 (USD Million)

• Instruments
• Consumables

Tissue Diagnostics Market By Technology, 2014-2025 (USD Million)

• H&E slide staining
• Immunohistochemistry (IHC)
  • IHC detection systems
  • IHC primary antibodies
  • Research IHC detection
  • Others
• In-situ hybridization (ISH)
  • ISH detection systems
  • Research ISH detection
  • ISH probes
  • Others
• Special staining
• Digital pathology
• Others

Tissue Diagnostics Industry By Application, 2014-2025 (USD Million)

• Prostate cancer
• Lung cancer
• Colorectal cancer
• Breast cancer
• Skin cancer
• Cervical cancer
• Lymphoma
• Gastric cancer
• Others

Tissue Diagnostics Industry By End-use, 2014-2025 (USD Million)

• Hospitals
• Pharmaceutical companies
• Research laboratories
• CROs
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

Company Profiles:

• Abbott Laboratories
• Agilent
• Merck
• Roche
• Danaher
• Thermo Fisher Scientific
• Sigma Aldrich
• BioGenex Laboratories
• Cancer Genetics
• Definiens
• Genomic Health

What Information does this report contain?